Cutting health care costs may get a little easier. The New York Times reports some drug companies are cutting deals with insurers that tie the cost of the drug to its performance.
Last week, Procter & Gamble and Sanofi-Aventis, joint sellers of Actonel, an osteoporosis drug, made an agreement with an insurer, Health Alliance, to reimburse the costs of treating fractures suffered by patients taking that medicine, the Times writes.
If Health Alliance customers who correctly use Actonel suffer a non-spinal fracture anyway, the drug companies will help pay for medical needed to treat it – up to $30,000 for a hip fracture, and $6,000 for a wrist fracture, according to the paper.
Continue Reading for Free
Register and gain access to:
- Breaking benefits news and analysis, on-site and via our newsletters and custom alerts
- Educational webcasts, white papers, and ebooks from industry thought leaders
- Critical converage of the property casualty insurance and financial advisory markets on our other ALM sites, PropertyCasualty360 and ThinkAdvisor
Already have an account? Sign In Now
© 2024 ALM Global, LLC, All Rights Reserved. Request academic re-use from www.copyright.com. All other uses, submit a request to [email protected]. For more information visit Asset & Logo Licensing.
